Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study
Objective To investigate the predictive value of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for the efficacy and prognosis of programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) inhibitors in driver-gene-negative advanced non-small-cell lung cancer...
| Váldodahkkit: | , , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
SAGE Publishing
2024-04-01
|
| Ráidu: | Technology in Cancer Research & Treatment |
| Liŋkkat: | https://doi.org/10.1177/15330338241246651 |
| _version_ | 1827284682463510528 |
|---|---|
| author | Qi Yuan MD Chunhua Xu MD Wei Wang MD Qian Zhang MD |
| author_facet | Qi Yuan MD Chunhua Xu MD Wei Wang MD Qian Zhang MD |
| author_sort | Qi Yuan MD |
| collection | DOAJ |
| description | Objective To investigate the predictive value of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for the efficacy and prognosis of programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) inhibitors in driver-gene-negative advanced non-small-cell lung cancer (NSCLC). Methods A retrospective analysis of 107 advanced NSCLC patients without gene mutations who received PD-1/PD-L1 inhibitors in our hospital from January 2020 to June 2022 was performed. NLR and PLR were collected before PD-1/PD-L1 inhibitors, the optimal cut-off values of NLR and PLR were determined according to the receiver operating characteristic (ROC) curve, and the effects of NLR and PLR on the efficacy of PD-1/PD-L1 inhibitors in advanced NSCLC patients were analyzed. Results A total of 107 patients were included in this study. Receiver operating characteristic analysis showed that the optimal cut-off values of NLR and PLR were 3.825, 179, respectively. Kaplan–Meier curve showed that low baseline levels NLR and PLR were associated with an improvement in both progression-free survival (PFS) ( P < .001, < .001, respectively) and overall survival (OS) ( P = .009, .006, respectively). In first-line treatment and non-first-line treatment, low baseline levels NLR and PLR were associated with an improvement in PFS. In multivariate analysis, low baseline NLR and PLR showed a strong association with both better PFS ( P = .011, .027, respectively) and longer OS ( P = .042, .039, respectively). Conclusion Low baseline NLR and PLR levels are significantly associated with better response in advanced NSCLC patients treated with PD-1/PD-L1 inhibitors, which may be indicators to predict the efficacy of immunotherapy in advanced NSCLC with driver-gene-negative. |
| first_indexed | 2024-04-24T10:01:36Z |
| format | Article |
| id | doaj.art-0468f7a2c9684591a171b11634ff8fd2 |
| institution | Directory Open Access Journal |
| issn | 1533-0338 |
| language | English |
| last_indexed | 2024-04-24T10:01:36Z |
| publishDate | 2024-04-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Technology in Cancer Research & Treatment |
| spelling | doaj.art-0468f7a2c9684591a171b11634ff8fd22024-04-13T10:04:59ZengSAGE PublishingTechnology in Cancer Research & Treatment1533-03382024-04-012310.1177/15330338241246651Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort StudyQi Yuan MDChunhua Xu MDWei Wang MDQian Zhang MDObjective To investigate the predictive value of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for the efficacy and prognosis of programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) inhibitors in driver-gene-negative advanced non-small-cell lung cancer (NSCLC). Methods A retrospective analysis of 107 advanced NSCLC patients without gene mutations who received PD-1/PD-L1 inhibitors in our hospital from January 2020 to June 2022 was performed. NLR and PLR were collected before PD-1/PD-L1 inhibitors, the optimal cut-off values of NLR and PLR were determined according to the receiver operating characteristic (ROC) curve, and the effects of NLR and PLR on the efficacy of PD-1/PD-L1 inhibitors in advanced NSCLC patients were analyzed. Results A total of 107 patients were included in this study. Receiver operating characteristic analysis showed that the optimal cut-off values of NLR and PLR were 3.825, 179, respectively. Kaplan–Meier curve showed that low baseline levels NLR and PLR were associated with an improvement in both progression-free survival (PFS) ( P < .001, < .001, respectively) and overall survival (OS) ( P = .009, .006, respectively). In first-line treatment and non-first-line treatment, low baseline levels NLR and PLR were associated with an improvement in PFS. In multivariate analysis, low baseline NLR and PLR showed a strong association with both better PFS ( P = .011, .027, respectively) and longer OS ( P = .042, .039, respectively). Conclusion Low baseline NLR and PLR levels are significantly associated with better response in advanced NSCLC patients treated with PD-1/PD-L1 inhibitors, which may be indicators to predict the efficacy of immunotherapy in advanced NSCLC with driver-gene-negative.https://doi.org/10.1177/15330338241246651 |
| spellingShingle | Qi Yuan MD Chunhua Xu MD Wei Wang MD Qian Zhang MD Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study Technology in Cancer Research & Treatment |
| title | Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study |
| title_full | Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study |
| title_fullStr | Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study |
| title_full_unstemmed | Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study |
| title_short | Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study |
| title_sort | predictive value of nlr and plr in driver gene negative advanced non small cell lung cancer treated with pd 1 pd l1 inhibitors a single institutional cohort study |
| url | https://doi.org/10.1177/15330338241246651 |
| work_keys_str_mv | AT qiyuanmd predictivevalueofnlrandplrindrivergenenegativeadvancednonsmallcelllungcancertreatedwithpd1pdl1inhibitorsasingleinstitutionalcohortstudy AT chunhuaxumd predictivevalueofnlrandplrindrivergenenegativeadvancednonsmallcelllungcancertreatedwithpd1pdl1inhibitorsasingleinstitutionalcohortstudy AT weiwangmd predictivevalueofnlrandplrindrivergenenegativeadvancednonsmallcelllungcancertreatedwithpd1pdl1inhibitorsasingleinstitutionalcohortstudy AT qianzhangmd predictivevalueofnlrandplrindrivergenenegativeadvancednonsmallcelllungcancertreatedwithpd1pdl1inhibitorsasingleinstitutionalcohortstudy |